Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 251 blog entries.

MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited)

Drug alert number: EL (25)A/04 Date issued: 30 January 2025 Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination. Amlodipine Bristol Lab 2.5 mg Tablets, PL 17907/0435 SNOMED Code: 38095611000001108 Batch Number Expiry Date Pack Size First Distributed MF23016 July 2025 28 29/9/2023 MF23017 [...]

The post MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited) appeared first on Community Pharmacy England.

By |January 30th, 2025|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited)

MHRA Drug Safety Update: January 2025

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 6 January 2025) has been published and includes articles on: GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation Letters and medicine recalls sent to healthcare professionals in December 2024 To see the latest [...]

The post MHRA Drug Safety Update: January 2025 appeared first on Community Pharmacy England.

By |January 28th, 2025|Lexpos News|Comments Off on MHRA Drug Safety Update: January 2025

Retrospective reimbursement price adjustments for Gaviscon Infant oral powder sachets

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has agreed to retrospectively adjust the reimbursement price of Gaviscon Infant oral powder 15 dual dose sachets for EPS prescriptions dispensed between May 2023 to November 2024. The term ‘dual dose sachets’ was updated to [...]

The post Retrospective reimbursement price adjustments for Gaviscon Infant oral powder sachets appeared first on Community Pharmacy England.

By |January 27th, 2025|Lexpos News|Comments Off on Retrospective reimbursement price adjustments for Gaviscon Infant oral powder sachets

Expiry of SSP075 Monomil® XL 60mg tablets

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Monomil® XL 60mg tablets is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP075 Monomil® XL 60mg tablets expires at 23.59pm on Friday 17 January 2025. After this date, any prescriptions for Monomil® XL 60mg [...]

The post Expiry of SSP075 Monomil® XL 60mg tablets appeared first on Community Pharmacy England.

By |January 17th, 2025|Lexpos News|Comments Off on Expiry of SSP075 Monomil® XL 60mg tablets

Update: Planned MYS downtime due to essential maintenance

Update 04/02/2025 – The NHS Business Services Authority (NHSBSA) has notified Community Pharmacy England that essential maintenance took place on the Manage Your Service (MYS) Pharmacy portal on Saturday 18 January 2025 as scheduled and as a result, there has been a change to the maintenance planned for the remaining two dates. Maintenance work will now [...]

The post Update: Planned MYS downtime due to essential maintenance appeared first on Community Pharmacy England.

By |January 17th, 2025|Lexpos News|Comments Off on Update: Planned MYS downtime due to essential maintenance